Standout Papers

Immunogenicity and safety of a third dose of CoronaVac, and immune persistence of a two-dose schedule, in healthy... 2021 2026 2022 2024170
  1. Immunogenicity and safety of a third dose of CoronaVac, and immune persistence of a two-dose schedule, in healthy adults: interim results from two single-centre, double-blind, randomised, placebo-controlled phase 2 clinical trials (2021)
    Gang Zeng, Qianhui Wu et al. The Lancet Infectious Diseases
  2. Modeling transmission of SARS-CoV-2 Omicron in China (2022)
    Jun Cai, Xiaowei Deng et al. Nature Medicine
  3. Global landscape of SARS-CoV-2 genomic surveillance and data sharing (2022)
    Andrew S. Azman, Xinhua Chen et al. Nature Genetics

Immediate Impact

14 from Science/Nature 58 standout
Sub-graph 1 of 22

Citing Papers

RSV Prefusion F Protein–Based Maternal Vaccine — Preterm Birth and Other Outcomes
2024 Standout
Alanyl-tRNA synthetase, AARS1, is a lactate sensor and lactyltransferase that lactylates p53 and contributes to tumorigenesis
2024 Standout
2 intermediate papers

Works of Juan Yang being referenced

Technical guidelines for the application of seasonal influenza vaccine in China (2014–2015)
2015
Fas-Mediated Apoptosis in Adriamycin-Induced Cardiomyopathy in Rats
2000

Author Peers

Author Last Decade Papers Cites
Juan Yang 1311 882 748 161 3.2k
Hui Jin 1139 742 318 217 3.5k
Shuo Feng 1167 2159 828 132 3.8k
Saki Takahashi 749 587 538 81 2.6k
Reiko Saito 898 2042 375 140 3.1k
Claúdio J. Struchiner 1737 1401 1075 211 5.9k
Ranjit Sah 1894 878 454 301 4.1k
Michael J. Mina 2111 1050 768 59 4.4k
Harapan Harapan 2418 591 803 145 5.1k
Yang Liu 667 587 356 156 2.7k
Edward Goldstein 1294 1431 1688 87 4.7k

All Works

Loading papers...

Rankless by CCL
2026